Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 533

    1.

    The positive predictive value of cervical smears in previously screened postmenopausal women: the Heart and Estrogen/progestin Replacement Study (HERS).

    Sawaya GF, Grady D, Kerlikowske K, Valleur JL, Barnabei VM, Bass K, Snyder TE, Pickar JH, Agarwal SK, Mandelblatt J.

    Ann Intern Med. 2000 Dec 19;133(12):942-50.PMID: 11119395 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Incidence of cervical cytological abnormalities with aging in the women's health initiative: a randomized controlled trial.

    Yasmeen S, Romano PS, Pettinger M, Johnson SR, Hubbell FA, Lane DS, Hendrix SL.

    Obstet Gynecol. 2006 Aug;108(2):410-9.PMID: 16880313 [PubMed - indexed for MEDLINE]Related articles

    3.

    Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

    Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN 3rd, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J; WHIMS Investigators.

    JAMA. 2003 May 28;289(20):2651-62.PMID: 12771112 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Estrogen plus progestin and risk of venous thrombosis.

    Cushman M, Kuller LH, Prentice R, Rodabough RJ, Psaty BM, Stafford RS, Sidney S, Rosendaal FR; Women's Health Initiative Investigators.

    JAMA. 2004 Oct 6;292(13):1573-80.PMID: 15467059 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.

    Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH; Women's Health Initiative Memory Study.

    JAMA. 2004 Jun 23;291(24):2947-58.PMID: 15213206 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

    Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E.

    JAMA. 1998 Aug 19;280(7):605-13.PMID: 9718051 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

    Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Gass ML, Stefanick ML, Lane DS, Hays J, Johnson KC, Coker LH, Dailey M, Bowen D; WHIMS Investigators.

    JAMA. 2003 May 28;289(20):2663-72.PMID: 12771113 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study.

    Grady D, Wenger NK, Herrington D, Khan S, Furberg C, Hunninghake D, Vittinghoff E, Hulley S.

    Ann Intern Med. 2000 May 2;132(9):689-96.PMID: 10787361 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial.

    Anderson GL, Judd HL, Kaunitz AM, Barad DH, Beresford SA, Pettinger M, Liu J, McNeeley SG, Lopez AM; Women's Health Initiative Investigators.

    JAMA. 2003 Oct 1;290(13):1739-48.PMID: 14519708 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

    Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women's Health Initiative Investigators.

    JAMA. 2002 Jul 17;288(3):321-33.PMID: 12117397 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Effect of estrogen therapy on gallbladder disease.

    Cirillo DJ, Wallace RB, Rodabough RJ, Greenland P, LaCroix AZ, Limacher MC, Larson JC.

    JAMA. 2005 Jan 19;293(3):330-9.PMID: 15657326 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

    Hulley S, Furberg C, Barrett-Connor E, Cauley J, Grady D, Haskell W, Knopp R, Lowery M, Satterfield S, Schrott H, Vittinghoff E, Hunninghake D; HERS Research Group.

    JAMA. 2002 Jul 3;288(1):58-66.PMID: 12090863 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.

    Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, Rodabough RJ, Gilligan MA, Cyr MG, Thomson CA, Khandekar J, Petrovitch H, McTiernan A; WHI Investigators.

    JAMA. 2003 Jun 25;289(24):3243-53.PMID: 12824205 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

    Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby LK, Waters D, Vittinghoff E, Wenger N; HERS Research Group.

    JAMA. 2002 Jul 3;288(1):49-57. Erratum in: JAMA 2002 Sep 4;288(9):1064. PMID: 12090862 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial.

    Kanaya AM, Herrington D, Vittinghoff E, Lin F, Grady D, Bittner V, Cauley JA, Barrett-Connor E; Heart and Estrogen/progestin Replacement Study.

    Ann Intern Med. 2003 Jan 7;138(1):1-9.PMID: 12513038 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Clinical evaluation of atypical glandular cells of undetermined significance.

    Geier CS, Wilson M, Creasman W.

    Am J Obstet Gynecol. 2001 Jan;184(2):64-9.PMID: 11174481 [PubMed - indexed for MEDLINE]Related articles

    18.

    Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial.

    Wassertheil-Smoller S, Hendrix SL, Limacher M, Heiss G, Kooperberg C, Baird A, Kotchen T, Curb JD, Black H, Rossouw JE, Aragaki A, Safford M, Stein E, Laowattana S, Mysiw WJ; WHI Investigators.

    JAMA. 2003 May 28;289(20):2673-84.PMID: 12771114 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial.

    Hlatky MA, Boothroyd D, Vittinghoff E, Sharp P, Whooley MA; Heart and Estrogen/Progestin Replacement Study (HERS) Research Group.

    JAMA. 2002 Feb 6;287(5):591-7.PMID: 11829697 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.

    McTiernan A, Martin CF, Peck JD, Aragaki AK, Chlebowski RT, Pisano ED, Wang CY, Brunner RL, Johnson KC, Manson JE, Lewis CE, Kotchen JM, Hulka BS; Women's Health Initiative Mammogram Density Study Investigators.

    J Natl Cancer Inst. 2005 Sep 21;97(18):1366-76.PMID: 16174858 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data